JDRF Rebrands as Breakthrough T1D to Accelerate Type 1 Research and Advocacy


On June 4, 2024, the Juvenile Diabetes Research Foundation (JDRF) announced that Breakthrough T1D was the new name for the organization.

During the organization’s annual Government Day meeting in Washington, D.C., the new name was announced in a global simulcast.

After a thorough, data-driven selection process, Breakthrough T1D was chosen because it more appropriately represents the non-profit’s capacity to engage with and support the whole type 1 diabetes community.

Type 1 diabetes is an autoimmune disease that causes the pancreas to create very little insulin or none at all. It was once thought that type 1 diabetes was a disorder that could only be detected in children—hence the name “juvenile diabetes.”

In actuality, type 1 diabetes can strike anyone at any age.

“For more than half a century, our organization has been at the forefront of type 1 diabetes research and advocacy, said Aaron J. Kowalski, PhD, CEO of Breakthrough T1D. “It is an honor to be CEO at this breakthrough moment as the organization takes a name that more accurately reflects our community and priorities.”

Breakthrough T1D’s new name is a reflection of its leadership in accelerating scientific research, therapeutic development, and the availability of medications and therapies for the T1D community.

“Our new name, Breakthrough T1D, puts our mission front and center. To accelerate life-changing breakthroughs to cure, prevent, and treat type 1 diabetes and its complications,” said Pam Morrisroe, chief marketing officer of Breakthrough T1D. “We developed this evolved brand in partnership with global experience firm Siegel+Gale through a nearly two-year data-driven process. Together, we have developed a visionary, powerful brand that more accurately reflects who we are: the world leader in type 1 diabetes research, advocacy, and community support.”

WRITTEN BY Daniel Trecroci, POSTED 06/04/24, UPDATED 06/05/24

Dan has written about diabetes for more than 20 years. He was one of Diabetes Health's first recruits, and throughout his 10 + years as Managing Editor he wrote/published thousands of articles and helped establish Diabetes Health as the premiere resource for people with diabetes. He later became the Content Manager for OneTouchGold—Johnson & Johnson/LifeScan’s official digital publication for its metering-technology customers. Under his leadership, OneTouchGold received the Web Marketing Association’s award for “Best Health & Wellness" web site. Dan has also written for the Diabetes Research Institute, dLife, diaTribe, Healthline, CareDx, Pendulum Therapeutics, and Hero Bread.